At the Cardiac Center at CHOP, we continue to research new ways to improve the lifelong health and well-being of children with CHD. Whether our physician-researchers are exploring the use of 3-D printing technology to improve surgical planning or searching for new ways to protect our cardiac patients’ brain health while they’re still in the womb, the goal of our research and innovation is always to improve patient outcomes today and advance care for the next generation of children born with heart disease.
Behind each breakthrough and every groundbreaking service we provide is the generous support of our donors. As a nonprofit organization, CHOP relies on donations to fund the medical advances that make our heart stories possible.
With the help of a 3-D printer, experts at The Children’s Hospital of Philadelphia are taking cardiac care into the next dimension.
Physicians at the Cardiac Center at CHOP are providing some innovative answers to how to decrease the amount of medical radiation patients receive during cardiac catheterization without compromising the quality of their care.
Using new lymphatic imaging tools and catheterization techniques, a team of experts from The Children’s Hospital of Philadelphia and the University of Pennsylvania eliminated bronchial casts from the airway of a 6-year-old patient.
Instead of focusing on protecting the brain during and after surgery, CHOP researchers and cardiothoracic surgeons want to find ways to protect the fetus’ brain before birth.
The Cardiac Center at CHOP has created the Coronary Anomaly Management Program (CAMP), the only program of its kind in the mid-Atlantic region, to provide comprehensive care and monitoring for children with a coronary artery anomaly.
Two case studies highlight that no two patients with a coronary anomaly are alike. The treatment and management depend on the coronary anatomy as well as symptoms and/or evidence of myocardial ischemia.
CHOP launches the Fetal Neuroprotection and Neuroplasticity Program, bringing together the deepest expertise to protect prenatal brain development in children with congenital heart defects.